Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
NN Kreis, F Louwen, J Yuan - Cancers, 2019 - mdpi.com
Loss of cell cycle control is characteristic of tumorigenesis. The protein p21 is the founding
member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein …
member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein …
PCNA: structure, functions and interactions
Z Kelman - Oncogene, 1997 - nature.com
Proliferating cell nuclear antigen (PCNA) plays an essential role in nucleic acid metabolism
as a component of the replication and repair machinery. This toroidal-shaped protein …
as a component of the replication and repair machinery. This toroidal-shaped protein …
Use of a cDNA microarray to analyse gene expression
J DeRisi, L Penland, M Bittner, PS Meltzer, M Ray… - Nat. genet, 1996 - nature.com
The development and progression of cancer1–3 and the experimental reversal of
tumorigenicity4, 5 are accompanied by complex changes in patterns of gene expression …
tumorigenicity4, 5 are accompanied by complex changes in patterns of gene expression …
Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing …
It has been proposed that the functions of the cyclin-dependent kinase inhibitors
p21Cip1/Waf1 and p27Kip1 are limited to cell cycle control at the G1/S-phase transition and …
p21Cip1/Waf1 and p27Kip1 are limited to cell cycle control at the G1/S-phase transition and …
p21WAF1 and tumourigenesis: 20 years after
Since its discovery, it has become increasingly clear that p21 can function as both a
classical tumour suppressor and an oncogene. In order to effectively utilize p21 as a …
classical tumour suppressor and an oncogene. In order to effectively utilize p21 as a …
Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks
Development of characteristic tissue patterns requires that individual cells be switched
locally between different phenotypes or “fates;” while one cell may proliferate, its neighbors …
locally between different phenotypes or “fates;” while one cell may proliferate, its neighbors …
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression
The controls that enable melanoblasts and melanoma cells to proliferate are likely to be
related, but so far no key regulator of cell cycle progression specific to the melanocyte …
related, but so far no key regulator of cell cycle progression specific to the melanocyte …
Differentiation therapy of human cancer: basic science and clinical applications
M Leszczyniecka, T Roberts, P Dent, S Grant… - Pharmacology & …, 2001 - Elsevier
Current cancer therapies are highly toxic and often nonspecific. A potentially less toxic
approach to treating this prevalent disease employs agents that modify cancer cell …
approach to treating this prevalent disease employs agents that modify cancer cell …
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer
TK MacLachlan, N Sang… - Critical Reviews™ in …, 1995 - dl.begellhouse.com
ABSTRACT A significant portion of cellular scientific literature published is dedicated to
describing the cloning, the link to cancer, or the characterization of proteins involved in the …
describing the cloning, the link to cancer, or the characterization of proteins involved in the …
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate …
X Zi, R Agarwal - Proceedings of the National Academy of Sciences, 1999 - pnas.org
Reduction in serum prostate-specific antigen (PSA) levels has been proposed as an
endpoint biomarker for hormone-refractory human prostate cancer intervention. We …
endpoint biomarker for hormone-refractory human prostate cancer intervention. We …